Copyright Reports & Markets. All rights reserved.

Global Eye Drug Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Eye Drug Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Eye Drug Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Eye Drug Market Size Growth Rate by Type
    • 1.4.2 Drops
    • 1.4.3 Tablet & Capsule
  • 1.5 Market by Application
    • 1.5.1 Global Eye Drug Market Size Growth Rate by Application
    • 1.5.2 Glaucoma
    • 1.5.3 Retinal Disease
    • 1.5.4 Bacterial?Infection
    • 1.5.5 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Eye Drug Market Size, Estimates and Forecasts
    • 2.1.1 Global Eye Drug Revenue 2015-2026
    • 2.1.2 Global Eye Drug Sales 2015-2026
  • 2.2 Global Eye Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Eye Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Eye Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Eye Drug Competitor Landscape by Players

  • 3.1 Eye Drug Sales by Manufacturers
    • 3.1.1 Eye Drug Sales by Manufacturers (2015-2020)
    • 3.1.2 Eye Drug Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Eye Drug Revenue by Manufacturers
    • 3.2.1 Eye Drug Revenue by Manufacturers (2015-2020)
    • 3.2.2 Eye Drug Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Eye Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Eye Drug Revenue in 2019
    • 3.2.5 Global Eye Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Eye Drug Price by Manufacturers
  • 3.4 Eye Drug Manufacturing Base Distribution, Product Types
    • 3.4.1 Eye Drug Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Eye Drug Product Type
    • 3.4.3 Date of International Manufacturers Enter into Eye Drug Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Eye Drug Market Size by Type (2015-2020)
    • 4.1.1 Global Eye Drug Sales by Type (2015-2020)
    • 4.1.2 Global Eye Drug Revenue by Type (2015-2020)
    • 4.1.3 Eye Drug Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Eye Drug Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Eye Drug Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Eye Drug Revenue Forecast by Type (2021-2026)
    • 4.2.3 Eye Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Eye Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Eye Drug Market Size by Application (2015-2020)
    • 5.1.1 Global Eye Drug Sales by Application (2015-2020)
    • 5.1.2 Global Eye Drug Revenue by Application (2015-2020)
    • 5.1.3 Eye Drug Price by Application (2015-2020)
  • 5.2 Eye Drug Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Eye Drug Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Eye Drug Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Eye Drug Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Eye Drug by Country
    • 6.1.1 North America Eye Drug Sales by Country
    • 6.1.2 North America Eye Drug Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Eye Drug Market Facts & Figures by Type
  • 6.3 North America Eye Drug Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Eye Drug by Country
    • 7.1.1 Europe Eye Drug Sales by Country
    • 7.1.2 Europe Eye Drug Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Eye Drug Market Facts & Figures by Type
  • 7.3 Europe Eye Drug Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Eye Drug by Region
    • 8.1.1 Asia Pacific Eye Drug Sales by Region
    • 8.1.2 Asia Pacific Eye Drug Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Eye Drug Market Facts & Figures by Type
  • 8.3 Asia Pacific Eye Drug Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Eye Drug by Country
    • 9.1.1 Latin America Eye Drug Sales by Country
    • 9.1.2 Latin America Eye Drug Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Eye Drug Market Facts & Figures by Type
  • 9.3 Central & South America Eye Drug Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Eye Drug by Country
    • 10.1.1 Middle East and Africa Eye Drug Sales by Country
    • 10.1.2 Middle East and Africa Eye Drug Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Eye Drug Market Facts & Figures by Type
  • 10.3 Middle East and Africa Eye Drug Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description and Business Overview
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Eye Drug Products Offered
    • 11.1.5 Pfizer Related Developments
  • 11.2 Novartis
    • 11.2.1 Novartis Corporation Information
    • 11.2.2 Novartis Description and Business Overview
    • 11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis Eye Drug Products Offered
    • 11.2.5 Novartis Related Developments
  • 11.3 bausch Lomb
    • 11.3.1 bausch Lomb Corporation Information
    • 11.3.2 bausch Lomb Description and Business Overview
    • 11.3.3 bausch Lomb Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 bausch Lomb Eye Drug Products Offered
    • 11.3.5 bausch Lomb Related Developments
  • 11.4 Laboratoire Riva
    • 11.4.1 Laboratoire Riva Corporation Information
    • 11.4.2 Laboratoire Riva Description and Business Overview
    • 11.4.3 Laboratoire Riva Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Laboratoire Riva Eye Drug Products Offered
    • 11.4.5 Laboratoire Riva Related Developments
  • 11.5 Jamp Pharma
    • 11.5.1 Jamp Pharma Corporation Information
    • 11.5.2 Jamp Pharma Description and Business Overview
    • 11.5.3 Jamp Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Jamp Pharma Eye Drug Products Offered
    • 11.5.5 Jamp Pharma Related Developments
  • 11.6 Fresenius
    • 11.6.1 Fresenius Corporation Information
    • 11.6.2 Fresenius Description and Business Overview
    • 11.6.3 Fresenius Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Fresenius Eye Drug Products Offered
    • 11.6.5 Fresenius Related Developments
  • 11.7 Teva Pharmaceutical?
    • 11.7.1 Teva Pharmaceutical? Corporation Information
    • 11.7.2 Teva Pharmaceutical? Description and Business Overview
    • 11.7.3 Teva Pharmaceutical? Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Teva Pharmaceutical? Eye Drug Products Offered
    • 11.7.5 Teva Pharmaceutical? Related Developments
  • 11.8 SANDOZ
    • 11.8.1 SANDOZ Corporation Information
    • 11.8.2 SANDOZ Description and Business Overview
    • 11.8.3 SANDOZ Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 SANDOZ Eye Drug Products Offered
    • 11.8.5 SANDOZ Related Developments
  • 11.9 Greenstone
    • 11.9.1 Greenstone Corporation Information
    • 11.9.2 Greenstone Description and Business Overview
    • 11.9.3 Greenstone Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Greenstone Eye Drug Products Offered
    • 11.9.5 Greenstone Related Developments
  • 11.10 Mylan
    • 11.10.1 Mylan Corporation Information
    • 11.10.2 Mylan Description and Business Overview
    • 11.10.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Mylan Eye Drug Products Offered
    • 11.10.5 Mylan Related Developments
  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description and Business Overview
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Eye Drug Products Offered
    • 11.1.5 Pfizer Related Developments
  • 11.12 Mint Pharmaceuticals
    • 11.12.1 Mint Pharmaceuticals Corporation Information
    • 11.12.2 Mint Pharmaceuticals Description and Business Overview
    • 11.12.3 Mint Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Mint Pharmaceuticals Products Offered
    • 11.12.5 Mint Pharmaceuticals Related Developments
  • 11.13 Laboratoires Thea
    • 11.13.1 Laboratoires Thea Corporation Information
    • 11.13.2 Laboratoires Thea Description and Business Overview
    • 11.13.3 Laboratoires Thea Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Laboratoires Thea Products Offered
    • 11.13.5 Laboratoires Thea Related Developments
  • 11.14 Taj Pharmaceuticals
    • 11.14.1 Taj Pharmaceuticals Corporation Information
    • 11.14.2 Taj Pharmaceuticals Description and Business Overview
    • 11.14.3 Taj Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Taj Pharmaceuticals Products Offered
    • 11.14.5 Taj Pharmaceuticals Related Developments
  • 11.15 Actavis
    • 11.15.1 Actavis Corporation Information
    • 11.15.2 Actavis Description and Business Overview
    • 11.15.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Actavis Products Offered
    • 11.15.5 Actavis Related Developments
  • 11.16 APOTEX
    • 11.16.1 APOTEX Corporation Information
    • 11.16.2 APOTEX Description and Business Overview
    • 11.16.3 APOTEX Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 APOTEX Products Offered
    • 11.16.5 APOTEX Related Developments
  • 11.17 Sun Pharma
    • 11.17.1 Sun Pharma Corporation Information
    • 11.17.2 Sun Pharma Description and Business Overview
    • 11.17.3 Sun Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Sun Pharma Products Offered
    • 11.17.5 Sun Pharma Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Eye Drug Market Estimates and Projections by Region
    • 12.1.1 Global Eye Drug Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Eye Drug Revenue Forecast by Regions 2021-2026
  • 12.2 North America Eye Drug Market Size Forecast (2021-2026)
    • 12.2.1 North America: Eye Drug Sales Forecast (2021-2026)
    • 12.2.2 North America: Eye Drug Revenue Forecast (2021-2026)
    • 12.2.3 North America: Eye Drug Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Eye Drug Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Eye Drug Sales Forecast (2021-2026)
    • 12.3.2 Europe: Eye Drug Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Eye Drug Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Eye Drug Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Eye Drug Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Eye Drug Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Eye Drug Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Eye Drug Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Eye Drug Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Eye Drug Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Eye Drug Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Eye Drug Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Eye Drug Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Eye Drug Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Eye Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Eye Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Eye Drug Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Eye Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Eye Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Eye Drug market is segmented into
    Drops
    Tablet & Capsule

    Segment by Application, the Eye Drug market is segmented into
    Glaucoma
    Retinal Disease
    Bacterial?Infection
    Other

    Regional and Country-level Analysis
    The Eye Drug market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Eye Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Eye Drug Market Share Analysis
    Eye Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Eye Drug business, the date to enter into the Eye Drug market, Eye Drug product introduction, recent developments, etc.

    The major vendors covered:
    Pfizer
    Novartis
    bausch Lomb
    Laboratoire Riva
    Jamp Pharma
    Fresenius
    Teva Pharmaceutical?
    SANDOZ
    Greenstone
    Mylan
    GE Medical
    Mint Pharmaceuticals
    Laboratoires Thea
    Taj Pharmaceuticals
    Actavis
    APOTEX
    Sun Pharma

    Buy now